Smith & Nephew
US Professional

Smith & Nephew Corporate

|

Select your country

Smith & Nephew

Advanced Search
  • Home
  • Products
  • Training and Education
  • Resources
  • News & Careers
  • Home
  • Products
  • Featured Products
  • IODOSORB/ IODOFLEX
  • Clinical Background
  • Home >
  • Products >
  • Featured Products >
  • IODOSORB/ IODOFLEX >
  • Clinical Background
  • Overview
  • Product in use
  • Technology
  • Clinical Background
    • IODOSORB/ IODOFLEX Glossary
  • FAQ
  • References
  • Contact
  • Print
  • Forward

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

    Visitor verfication

Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew

IODOSORB™/IODOFLEX™

0.9% Cadexomer Iodine Gel and Pads

Clinical Background

  • Overview
  • Product in use
  • Technology
  • Clinical Background ...
  • FAQ
  • References

Expert Statement

Iodosorb Iodoflec Clinical Background Vincent Falanga, MD

Vincent Falanga, MD
Professor of Dermatology and Biochemistry

 

 

 

"The development of slow-release antiseptic agents, such as those based on iodine, has rendered antiseptics safe, effective, and reliable in the management of difficult wounds. In my own practice, I have found these therapeutic agents particularly useful in the bacterial "de-colonization" of chronic wounds, an important step in the overall approach to wound bed preparation. As a result, patient management is greatly facilitated, whether one is simply applying standard treatments or using more advanced therapies. The bacterial burden decreases, as does wound exudate. Quite frankly, I don't know what I would do without the use of slow-release antiseptics, particularly in the outpatient setting. I do know that some of my clinician colleagues are still fearful of the word "antiseptics". This fear is rooted in old literature on the use of "straight" antiseptics, with no mechanisms for slow and smart delivery. However, in the field of medicine and in caring for patients, one needs to adapt while remaining critical, and most of all be vigilant about new opportunities that can help our patients.

Case studies

Dr Marazzi treats 3 patients with Diabetic Foot Ulcers:

Case study 1 Female, 39 years old, with diabetic ulcer in her right foot for 2 years. Iodosorb Clinical Background Case Study 1 
Case study 2 Male, 65 years old, with diabetic ulcers of the right foot. Iodosorb Clinical Background Case Study 2
Case study 3 Male, 66 years old, with diabetic ulcer (right foot) for 2 months. Iodosorb Clinical Background Case Study 3

Dr Gordon Dow presents on the use of IODOSORB◊ in various etiologies:

  • Pressure Ulcers  
  • Diabetic & Venous Ulcers  
  • Summary

Click here to view a summary of the Dow slides above

  • References
  • Glossary
  • Click here to view IODOSORB◊ Product Insert
  • Click here to view IODOFLEX◊ Product Insert
  • ◊ Trademark of Smith & Nephew | This information intended for United States customers only
  • Accessibility
  • Copyright & Disclaimer